| Product Name | MF | CAS | Details |
|---|
| Filipin II | C35H58O10 | 38620-77-8 | Details |
| 3-Formyl-4-hydroxybenzoic acid | C8H6O4 | 584-87-2 | Details |
| (Tyr9)-beta-MSH (porcine) trifluoroacetate salt | C101H140N24O30S | 198281-81-1 | Details |
| Octanoyl D-glucopyranoside | C14H26O7 | 60415-65-8 | Details |
| (E)-N-(3-Benzylidene-9-oxo-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-6-yl)-3-(piperidin-1-yl)propanamide | C26H28N4O2 | 90263-34-6 | Details |
| 1-(1,3-Diphenyl-1H-pyrazole-4-carbothioyl)piperidine | C21H21N3S | 312746-22-8 | Details |
| Methyl red | C15H15N3O2 | 493-52-7 | Details |
| 3-{[(4-Chlorophenyl)sulfanyl]methyl}benzoic acid | C14H11ClO2S | 30082-41-8 | Details |
| CA 15-3, Part Purified | Details |
| beta-Cypermethrin | C22H19Cl2NO3 | 65731-84-2 | Details |
| Erucic acid 98% | C22H42O2 | 112-86-7 | Details |
| 1-{4-[(Difluoromethyl)sulfanyl]phenyl}ethan-1-one | C9H8F2OS | 145326-60-9 | Details |
| 2-((4-methylphenyl)sulfonyl)-3-(pyrimidin-2-ylamino)prop-2-enenitrile | C14H12N4O2S | 1025124-03-1 | Details |
| [4,4'-Di-t-butyl-2,2'-bipyridine][bis[5-(t-butyl)-2-[4-(t-butyl)-2-pyridinyl-kN]phenyl-kC]iridium(III) hexafluorophosphate | C56H72F6IrN4P | 808142-80-5 | Details |
| ZB716 | C32H48BF5O4S | 1853279-29-4 | Details |
| 6-Methyl-5H,6H,7H,8H-imidazo[1,2-a]pyridine-2-carboxylic acid hydrochloride | C9H13ClN2O2 | 2060006-29-1 | Details |
| 5-Cyclopropyl-1,2,4-thiadiazol-3-amine | C5H7N3S | 1342142-02-2 | Details |
| MOV10L1 antibody | Details |
| ZNF200 antibody | Details |
| TCEB3C antibody | Details |
| 14-3-3 Ε, Untagged human | 1173938-17-4 | Details |
| Methyl 2-(4-(aminomethyl)phenyl)acetate hydrochloride | C10H14ClNO2 | 99075-25-9 | Details |
| 2-(1,2,3,4-Tetrahydroisoquinolin-5-yl)acetamide | C11H14N2O | 1894628-49-9 | Details |
| Ethyl 2-(aminomethyl)-2-ethylbutanoate | C9H19NO2 | 90726-82-2 | Details |
| Pyrylium tetrafluoroborate | C5H5BF4O | 80279-50-1 | Details |
| CD32 antibody (Tyr292) | Details |
| 2-((4-chlorophenyl)sulfonyl)-3-(4-(5-(trifluoromethyl)(2-pyridyloxy))phenyl)prop-2-enenitrile | C21H12ClF3N2O3S | 1025270-09-0 | Details |
| 3-Bromofuran-2-sulfonyl chloride | C4H2BrClO3S | 930111-08-3 | Details |
| DJ1 antibody (HRP) | Details |
| 4-Chloro-2-methoxybenzoic acid | C8H7ClO3 | 57479-70-6 | Details |
| (R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | C14H18O4 | 53101-49-8 | Details |
| rac styrene oxide | C8H8O | 96-09-3 | Details |
| 2-Chloro-1-[4-(2-chlorobenzenesulfonyl)piperazin-1-yl]ethan-1-one | C12H14Cl2N2O3S | 923756-84-7 | Details |
| Sodium percarbonate | CH5NaO5 | 15630-89-4 | Details |
| Halosulfuron | C12H13ClN6O7S | 135397-30-7 | Details |
| 2-Hydroxy-4-phenylbutanoic acid | C10H12O3 | 4263-93-8 | Details |
| Metomidate hydrochloride | C13H14N2O2.ClH | 35944-74-2 | Details |
| Chloraniformethan | C9H7Cl5N2O | 20856-57-9 | Details |
| 2-Boc-8-amino-5-thia-2-azaspiro[3.4]octane 5,5-dioxide | C11H20N2O4S | 1340481-83-5 | Details |
| 6-Bromo-5-chloro-1H-imidazo[4,5-b]pyridin-2(3H)-one | C6H3BrClN3O | 1207627-28-8 | Details |
| DL-Pipecolinic acid | C6H11NO2 | 535-75-1 | Details |
| Foeniculin | C14H18O | 78259-41-3 | Details |
| OR2W1 Blocking Peptide | Details |
| KB-R7943 | C17H21N3O6S2 | 182004-65-5 | Details |
| 11,13-Dimethyl-5-[(pyridin-3-yl)methyl]-4,5,7,11,13-pentaazatricyclo[7.4.0.0,2,6]trideca-1,3,6,8-tetraene-10,12-dione | C16H14N6O2 | 2193064-94-5 | Details |
| 4-Chloro-2-iodopyridin-3-ol | C5H3ClINO | 188057-56-9 | Details |
| tert-Butyl 6-benzyl-octahydro-1H-pyrrolo[3,4-b]pyridine-1-carboxylate | C19H28N2O2 | 159877-35-7 | Details |
| Ethyl({2-[4-(trifluoromethyl)phenyl]ethyl})amine | C11H14F3N | 1199779-59-3 | Details |
| 5-Hydroxy-2-nitrobenzoic acid | C7H5NO5 | 610-37-7 | Details |
| 2-Deoxy-5-O-toluoyl-D-ribofuranose | C13H16O5 | 1195620-56-4 | Details |
| Polyglycerine - Polyglycerol-2,3,4 | C3H8O3 | 25618-55-7 | Details |
| [3-(Dimethoxymethyl)phenyl]methanamine | C10H15NO2 | 124283-46-1 | Details |
| (5±)-Androsta-2,16-dien-17-ol 17-Acetate | C21H30O2 | 50588-42-6 | Details |
| 3-(Methylsulfanyl)azepane | C7H15NS | 1423031-54-2 | Details |
| N-Cbz-2-morpholinecarboxylic acid | C13H15NO5 | 135782-21-7 | Details |
| 3-(3-Methoxyphenyl)-3-methylpyrrolidine hydrochloride | C12H18ClNO | 1236862-24-0 | Details |
| 5,8-dimethoxyquinoline | C11H11NO2 | 58868-41-0 | Details |
| 1,3,4,6-Tetra-O-acetyl-2-O-nonafluorobutane-sulfonyl-b-D-mannopyranose | C18H19F9O12S | 480438-48-0 | Details |
| 3-Bromo-4-fluoro-N-(pyridin-4-ylmethyl)aniline hydrochloride | C12H11BrClFN2 | 1864015-94-0 | Details |
| 1-Amino-3-(3-methylphenoxy)propan-2-ol | C10H15NO2 | 4698-88-8 | Details |
| ZO3 antibody | Details |
| 3-Methyl-4H,6H,7H-furo[3,2-c]pyran-4,6-dione | C8H6O4 | 146983-81-5 | Details |
| 4-Methyl-1,2,5-oxadiazole-3-carbonyl chloride | C4H3ClN2O2 | 15323-68-9 | Details |
| FADD protein (His tag) | Details |
| CSNK1D antibody | Details |
| FBXO7 Blocking Peptide | Details |
| N-(2-Aminoethyl)-3-bromoaniline | C8H11BrN2 | 14088-81-4 | Details |
| Cytochrome B5 Reductase 3, human, recombinant | Details |
| 1,5-Dimethyl-1,4-diazepane | C7H16N2 | 150651-59-5 | Details |
| (3-phenoxyphenyl)methyl 3-((4,6-dimethylpyrimidin-2-yl)amino)-2-nitriloprop-2-enoate | C23H20N4O3 | 1025628-94-7 | Details |
| tert-butyl N-(2-oxo-2-phenylethyl)carbamate | C13H17NO3 | 76477-26-4 | Details |
| 4,5-Dimethylpyridazine-3,6-diol | C6H8N2O2 | 5754-17-6 | Details |
| 4-(Methanesulfonylmethyl)-4-methylpiperidine hydrochloride | C8H17NO2S.ClH | 2248341-86-6 | Details |
| Ethyl 4-(oxan-4-yl)-2,4-dioxobutanoate | C11H16O5 | 1560898-02-3 | Details |
| 2-(3-Methylbutanoyl)indane-1,3-dione | C14H14O3 | 83-28-3 | Details |
| Lumiracoxib acyl-β-D-glucuronide | C21H21ClFNO8 | 697287-17-5 | Details |
| Ethyl 5-acetyl-6-oxo-1,6-dihydropyridine-3-carboxylate | 2106243-32-5 | Details |
| 3-[(3-Chlorophenyl)sulfamoyl]-4-methylbenzoic acid | C14H12ClNO4S | 438021-88-6 | Details |
| (2-Ethoxy-4-formyl-phenoxy)-acetic acid | C11H12O5 | 51264-76-7 | Details |
| 3-Bromo-5-tert-butylphenol | C10H13BrO | 1047661-26-6 | Details |
| Sheep IgG (Fc) | Details |
| Methyl 3-[3-(dimethylamino)phenyl]propanoate | C12H17NO2 | 1234503-56-0 | Details |
| 2-(1-Methoxycyclopropyl)ethan-1-amine hydrochloride | C6H14ClNO | 2227206-60-0 | Details |
| 2-Amino-1-(1-piperidinyl)-1-ethanone hydrochloride | C7H15ClN2O | 5437-48-9 | Details |
| 5-Amino-2-(4-hydroxypiperidin-1-yl)benzonitrile | C12H15N3O | 288251-78-5 | Details |
| MART-1 (27-35) (human) | C37H67N9O11 | 156251-11-5 | Details |
| 2-(2-(3-bromophenyl)-2-oxoethyl)-5-methylcyclohexane-1,3-dione | C15H15BrO3 | 1024188-94-0 | Details |
| N-(3-Methylpyridin-2-yl)piperidine-4-carboxamide | C12H17N3O | 110105-98-1 | Details |
| 1,6-Dinitropyrene | C16H8N2O4 | 42397-64-8 | Details |
| 1-(1H-Indazole-5-amido)cyclopentane-1-carboxylic acid | C14H15N3O3 | 1099147-55-3 | Details |
| [(2,3-Dichlorophenyl)methyl]hydrazine hydrochloride | C7H9Cl3N2 | 1318769-38-8 | Details |
| (4-Fluoro-1-benzothiophen-2-yl)boronic acid | C8H6BFO2S | 1416853-79-6 | Details |
| 3,8-Dioxabicyclo[3.2.1]octane-2,4-dione | C6H6O4 | 54885-06-2 | Details |
| [Cys] citrullinated alpha enolase | Details |
| GrTx1 | Details |
| H-RPRGEVRFL-OH | Details |
| 3-(1H-Imidazol-1-yl)pyrazine-2-carboxylic acid | C8H6N4O2 | 717848-23-2 | Details |
| Cat RBC antibody (FITC) | Details |
| 5-Ethyl-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-amine hydrochloride | C12H13ClF3N3 | 1795509-80-6 | Details |
| C5ORF35 Blocking Peptide | Details |
| Product Total： Product Page： | ||||
| 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 | ||||